Apertura Gene Therapy logo

Apertura Gene Therapy Employee Directory

Biotechnology ResearchNew York, United States2-10 Employees

Apertura Gene Therapy is a biotechnology company focused on developing next-generation adeno-associated virus (AAV) gene therapies to address diseases with limited treatment options. The company advances programs by engineering multiple components of gene delivery to overcome existing barriers in genetic medicine, aiming to enable systemic and central nervous system delivery. Its work is grounded in technologies from the Broad Institute and Harvard University, and the organization operates from New York, New York. Apertura has pursued collaborations and partnerships to progress therapeutic programs, including efforts related to tuberous sclerosis complex (TSC), and has engaged with multiple collaborators to advance TfR1 CapX, a platform describing its approach to delivery. Recent activities include partnerships and program developments announced in 2026, reflecting ongoing collaboration with patient-focused organizations and participation in scientific meetings. The firm positions itself within the biotechnology research sector, emphasizing the development of gene therapies and delivery technologies to expand treatment possibilities for serious genetic diseases.

Find Apertura Gene Therapy employees' phone numbers or email addresses

Apertura Gene Therapy Global Highlights

Location
Employees

North America
7

Minus sign iconPlus sign icon
  • United States Of America
    7

Apertura Gene Therapy's Leadership

  • Chief Business Officer at Apertura Gene Therapy
    D. J. G.
    Chief Business Officer
  • Associate Director, Technical Operations at Apertura Gene Therapy
    V. W.
    Associate Director, Technical Operations
  • Senior Research Associate, Analytical Development at Apertura Gene Therapy
    A. S.
    Senior Research Associate, Analytical Development
  • Board Member at Apertura Gene Therapy
    J. L. B.
    Board Member
  • Vice President, Chemistry, Manufacturing, And Controls (cmc) & Regulatory Affairs at Apertura Gene Therapy
    J. S.
    Vice President, Chemistry, Manufacturing, And Controls (cmc) & Regulatory Affairs
  • Director, Nonclinical And Translational Research at Apertura Gene Therapy
    C. D.
    Director, Nonclinical And Translational Research

Apertura Gene Therapy Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Entrepreneurship
  • Sales
  • Legal
  • Other

Contact profiles from Apertura Gene Therapy

Name
Title
Contact
Location
Last Update
  • Chief Business Officer at Apertura Gene Therapy
    D. J. G.
    Chief Business Officer
    United States, New York
    Jun 01, 2026
  • Associate Director, Technical Operations at Apertura Gene Therapy
    V. W.
    Associate Director, Technical Operations
    United States, New York
    Jun 01, 2026
  • Senior Research Associate, Analytical Development at Apertura Gene Therapy
    A. S.
    Senior Research Associate, Analytical Development
    United States, New York
    Jun 01, 2026
  • Board Member at Apertura Gene Therapy
    J. L. B.
    Board Member
    United States, Pennsylvania
    Jun 01, 2026
  • Vice President, Chemistry, Manufacturing, And Controls (cmc) & Regulatory Affairs at Apertura Gene Therapy
    J. S.
    Vice President, Chemistry, Manufacturing, And Controls (cmc) & Regulatory Affairs
    United States, New York
    Jun 04, 2026
  • Director, Nonclinical And Translational Research at Apertura Gene Therapy
    C. D.
    Director, Nonclinical And Translational Research
    United States, Massachusetts
    Apr 13, 2026

Frequently Asked Questions

What is Apertura Gene Therapy known for?

Minus sign iconPlus sign icon
Apertura Gene Therapy operates in the Biotechnology Research industry. Explore Apertura Gene Therapy's company overview page for more information.

What is Apertura Gene Therapy's most common email format?

Minus sign iconPlus sign icon
Apertura Gene Therapy employees' email format typically follows the pattern of FLast@aperturagtx.com. Trying to find reliable and up-to-date employee contact data? Find more Apertura Gene Therapy email formats with LeadIQ.

How many employees does Apertura Gene Therapy have currently?

Minus sign iconPlus sign icon
Apertura Gene Therapy has approximately 8 employees as of August 2026. These team members are located across 1 continents, including North America.

Who are Apertura Gene Therapy's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Apertura Gene Therapy's key employees include:

  • Chief Business Officer: D. J. G.
  • Associate Director, Technical Operations: V. W.
  • Senior Research Associate, Analytical Development: A. S.
  • Board Member: J. L. B.
  • Vice President, Chemistry, Manufacturing, And Controls (cmc) & Regulatory Affairs: J. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.